EPIC Program Annual Data Tables 2003-2004: Table IX

Table IX
Top Twenty Drugs Based on EPIC Payments
Rank by
Payment
DrugStrengthDrug
Type**
Number
of Claims
EPIC PaymentsRank by Number
of Claims
Top 20 Totals1,550,111$214,167,566
Percent of Top 20 Drugs to Total EPIC Payments14.4%30.8%
1PLAVIX75MGSS142,603$24,139,3334
2PREVACID30MGSS85,308$16,651,28115
3LIPITOR10MGSS169,555$16,417,3212
4FOSAMAX70MGSS157,348$14,976,3763
5NEXIUM40MGSS75,799$14,890,07418
6LIPITOR20MGSS97,203$14,303,22711
7ZOCOR20MGSS69,816$13,697,84722
8PROTONIX40MGSS99,061$13,430,81310
9CELEBREX200MGSS87,296$11,322,42814
10ZOCOR40MGSS42,561$8,287,74040
11PRAVACHOL40MGSS40,735$8,060,61347
12NORVASC5MGSS128,481$7,740,3137
13PROCRIT40000 U/MLBNMS4,066$7,723,746480
14NORVASC10MGSS87,843$7,033,64213
15ARICEPT10MGSS39,782$6,531,20349
16OMEPRAZOLE20MGGen39,697$6,454,47950
17LIPITOR40MGSS38,791$5,908,48953
18ACIPHEX20MGSS31,492$5,891,24771
19VIOXX25MGSS51,144$5,471,92432
20ACTONEL35MGSS61,530$5,235,47024

* Table IX lists the top 20 drugs ranked by EPIC Payments and number of adjudicated claims for the program year (October 1, 2003-September 30, 2004) as well as the percentage of the totals they represent for the year.

** Drug Type values are BNMS='Brand Name Multi-Source', Gen='Generic' and SS='Sole Source'.